Strides Pharma hits 52-week high on reporting turnaround Q1 performance

Strides Pharma Science added 2.46% to Rs 1,053.75 after the company reported a consolidated net profit of Rs 70.20 crore in Q1 FY25 as against a net loss of Rs 7.11 crore posted in Q1 FY24.

By: business-standard.com

Jul 29 2024
0
0 Views

Strides Pharma hits 52-week high on reporting turnaround Q1 performance

Digitalization is driving growth in services exports and lowering remittance costs says RBI

Adani Total Gas gains after Q1 PAT jumps 20% YoY to Rs 177 cr in FY25

Tainwala Chemicals & Plastics (India) standalone net profit rises 203.85% in the June 2024 quarter

Gujarat Poly Electronics standalone net profit declines 29.17% in the June 2024 quarter

Kansai Nerolac Paints consolidated net profit declines 68.72% in the June 2024 quarter

Jai Balaji Industries consolidated net profit rises 22.53% in the June 2024 quarter

ASK Automotive consolidated net profit rises 63.12% in the June 2024 quarter

Axis Securities picks PI Industries as 'Stock Pick of the Week'; Check Why

Spandana Sphoorty slips 8%, hits 52-week low on disappointing Q1 results

Euro currency speculators further increase net long positions

Board of Wonderla Holidays approves exploration of fund raising options

Share this page

Guest Posts by Easy Branches

anchor links ads by Easy Branches

Get Reliable Matka Guessing Forum with our Satta Matka Expert and Get all Matka Chart For Free.

Strides Pharma hits 52-week high on reporting turnaround Q1 performance

Related